Breaking News Instant updates and real-time market news.

FHN

First Horizon

06:08
11/28/16
11/28
06:08
11/28/16
06:08

First Horizon upgraded to Buy from Hold at Jefferies

Jefferies analyst Casey Haire upgraded First Horizon National saying the shares do not fully reflect upside potential from a better environment for capital markets activity. The analyst raised his price target for the shares to $22 from $18.

FHN First Horizon

01/11/16
EVER
01/11/16
UPGRADE
Target $15
EVER
Buy
First Horizon upgraded to Buy from Hold at Evercore ISI
Evercore ISI analyst John Pancari upgraded First Horizon to Buy with a $15 price target citing the recent pullback in shares, improving loan trends, and a modest improvement in capital markets activity.
01/11/16
01/11/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AU Optronics (AUO) upgraded to Neutral from Underweight at JPMorgan... Air Products (APD) upgraded to Overweight from Sector Weight at KeyBanc... Amedisys (AMED) upgraded to Market Perform from Underperform at Raymond James... Ameriprise (AMP) upgraded to Outperform from Neutral at Credit Suisse... Analog Devices (ADI) upgraded to Outperform from Market Perform at Wells Fargo... Apple (AAPL) upgraded to Buy from Neutral at Mizuho... BAE Systems (BAESY) upgraded to Overweight from Neutral at JPMorgan... BNP Paribas (BNPQY) upgraded to Buy from Hold at Deutsche Bank... BNY Mellon (BK) upgraded to Conviction Buy from Neutral at Goldman... Banco Santander (SAN) upgraded to Outperform from Underperform at Exane BNP Paribas... Beiersdorf (BDRFF) upgraded to Neutral from Sell at Goldman... CEVA (CEVA) upgraded to Buy from Neutral at Ladenburg... Celanese (CE) upgraded to Buy from Neutral at SunTrust... Children's Place (PLCE) upgraded to Overweight at Morgan Stanley... Citizens Financial (CFG) upgraded to Buy from Neutral at Goldman... Clayton Williams (CWEI) upgraded to Market Perform from Underperform at Cowen... Concho Resources (CXO) upgraded to Outperform from Market Perform at Cowen... Crane (CR) upgraded to Buy from Hold at Vertical Research... Credit Agricole (CRARY) upgraded to Buy from Hold at Deutsche Bank... Denbury Resources (DNR) upgraded to Market Perform from Underperform at Cowen... Devon Energy (DVN) upgraded to Overweight from Equal Weight at Barclays... Discover (DFS) upgraded to Buy from Hold at Evercore ISI... Energen (EGN) upgraded to Outperform from Market Perform at Cowen... FS Investment (FSIC) upgraded to Buy from Hold at Cantor... First Horizon (FHN) upgraded to Buy from Hold at Evercore ISI... General Dynamics (GD) upgraded to Outperform from Market Perform at Cowen... General Motors (GM) upgraded to Outperform from Neutral at Credit Suisse... Genesco (GCO) upgraded to Overweight at Morgan Stanley... Hanesbrands (HBI) upgraded to Buy from Neutral at Nomura... Imperva (IMPV) upgraded to Buy from Neutral at Guggenheim... International Paper (IP) upgraded to Outperform from Sector Perform at RBC Capital... KeyCorp (KEY) upgraded to Buy from Neutral at Goldman... LVMH (LVMUY) upgraded to Neutral from Underperform at Credit Suisse... Laredo Petroleum (LPI) upgraded to Outperform from Market Perform at Cowen... Marathon Oil (MRO) upgraded to Overweight from Equal Weight at Barclays... Medifast (MED) upgraded to Buy from Neutral at Sidoti... Melco Crown (MPEL) upgraded to Overweight from Equal Weight at Morgan Stanley... Mellanox (MLNX) upgraded to Outperform on leverage to data growth at Credit Suisse... NASDAQ (NDAQ) upgraded to Neutral from Sell at Goldman... Newfield Exploration (NFX) upgraded to Outperform from Market Perform at Wells Fargo... OMA Airports (OMAB) upgraded to Neutral from Sell at Goldman... ONEOK (OKE) upgraded to Buy from Hold at Argus... Owens Corning (OC) upgraded on favorable risk/reward at RBC Capital... Patterson-UTI (PTEN) upgraded to Outperform from Market Perform at Wells Fargo... Pinnacle Foods (PF) upgraded to Outperform from Market Perform at BMO Capital... Pioneer Natural (PXD) upgraded to Equal Weight from Underweight at Barclays... RPC, Inc. (RES) upgraded to Outperform from Market Perform at Wells Fargo... RSP Permian (RSPP) upgraded to Outperform from Market Perform at Cowen... Rayonier Advanced Materials (RYAM) upgraded to Sector Perform from Underperform at RBC Capital... Regal-Beloit (RBC) upgraded to Overweight from Equal Weight at Morgan Stanley... Sanderson Farms (SAFM) upgraded to Overweight from Neutral at JPMorgan... Santander Mexico (BSMX) upgraded to Neutral from Underperform at BofA/Merrill... Southwest (LUV) upgraded to Equal Weight from Underweight at Morgan Stanley... Spectra Energy Partners (SEP) upgraded to Overweight from Equal Weight at Barclays... Superior Energy (SPN) upgraded to Outperform from Market Perform at Wells Fargo... Syntel (SYNT) upgraded to Neutral from Underweight at JPMorgan... U.S. Silica (SLCA) upgraded to Outperform from Market Perform at Wells Fargo... United Bankshares (UBSI) upgraded to Neutral at Boenning & Scattergood... Virtu Financial (VIRT) upgraded to Buy from Neutral at Goldman... Weatherford (WFT) upgraded to Outperform from Market Perform at Wells Fargo... Wells Fargo (WFC) upgraded to Buy from Neutral at Goldman... Whiting Petroleum (WLL) upgraded to Outperform from Market Perform at Wells Fargo... Wyndham (WYN) upgraded to Hold from Sell at Deutsche Bank.
08/23/16
WELS
08/23/16
DOWNGRADE
WELS
Underperform
First Horizon downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Jared Shaw downgraded First Horizon to Underperform saying premium valuation likely eliminates the company as a near-term seller and sees a chance of potential dilution if management acquires another institution.
09/26/16
HOVD
09/26/16
DOWNGRADE
HOVD
Market Perform
First Horizon downgraded to Market Perform from Outperform at Hovde Group

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$57.21

-1.3 (-2.22%)

17:09
12/04/16
12/04
17:09
12/04/16
17:09
Conference/Events
Starbucks to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CS

Credit Suisse

$13.39

-0.34 (-2.48%)

17:03
12/04/16
12/04
17:03
12/04/16
17:03
Conference/Events
Credit Suisse to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 14

    Dec

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

, SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

17:02
12/04/16
12/04
17:02
12/04/16
17:02
Hot Stocks
Takeda Pharma, Seattle Genetics reports Phase 3 ADCETRIS data »

Takeda Pharmaceutical…

TKPYY

Takeda Pharmaceutical Co. Ltd.

$20.40

0.135 (0.67%)

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

CGEN

Compugen

$5.95

0.1 (1.71%)

16:59
12/04/16
12/04
16:59
12/04/16
16:59
Conference/Events
Compugen to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

QURE

uniQure

$5.68

-0.31 (-5.18%)

16:56
12/04/16
12/04
16:56
12/04/16
16:56
Hot Stocks
uniQure reports data on AMT-060 in hemophilia B »

uniQure announced new and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 08

    Dec

RGLS

Regulus

$2.50

0.1 (4.17%)

16:53
12/04/16
12/04
16:53
12/04/16
16:53
Conference/Events
Regulus to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

PBI

Pitney Bowes

$14.63

0.1 (0.69%)

16:52
12/04/16
12/04
16:52
12/04/16
16:52
Conference/Events
Pitney Bowes to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

16:43
12/04/16
12/04
16:43
12/04/16
16:43
Hot Stocks
Seattle Genetics reports Phase 1b vadastuximab talirine data, plans Ph. 2 trial »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NVS

Novartis

$68.17

0.42 (0.62%)

16:38
12/04/16
12/04
16:38
12/04/16
16:38
Hot Stocks
Novartis reports Phase 2 SEG101 data »

Novartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PFE

Pfizer

$31.63

0.17 (0.54%)

16:33
12/04/16
12/04
16:33
12/04/16
16:33
Hot Stocks
Pfizer reports Phase 2 glasdegib data »

Pfizer announced new data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

EKSO

Ekso Bionics

$4.27

-0.11 (-2.51%)

16:30
12/04/16
12/04
16:30
12/04/16
16:30
Conference/Events
Ekso Bionics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ADSK

Autodesk

$70.57

1.35 (1.95%)

16:24
12/04/16
12/04
16:24
12/04/16
16:24
Conference/Events
Autodesk to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Jan

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

16:23
12/04/16
12/04
16:23
12/04/16
16:23
Hot Stocks
Seattle Genetics reports Phase 2 ADCETRIS lymphoma data, says discontinues trial »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FTI

FMC Technologies

$35.60

0.9 (2.59%)

, TKPPY

Technip

$17.80

0.45 (2.59%)

16:21
12/04/16
12/04
16:21
12/04/16
16:21
Conference/Events
Technip to host special shareholder meeting »

Special Shareholder…

FTI

FMC Technologies

$35.60

0.9 (2.59%)

TKPPY

Technip

$17.80

0.45 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

TKPPY

Technip

$17.80

0.45 (2.59%)

, FTI

FMC Technologies

$35.60

0.9 (2.59%)

16:14
12/04/16
12/04
16:14
12/04/16
16:14
Conference/Events
FMC Technologies to host special shareholder meeting »

Special Shareholder…

TKPPY

Technip

$17.80

0.45 (2.59%)

FTI

FMC Technologies

$35.60

0.9 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

16:04
12/04/16
12/04
16:04
12/04/16
16:04
Hot Stocks
Alnylam reports interim Phase 1 data on fitusiran »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADRO

Aduro Biotech

$10.80

0.25 (2.37%)

16:01
12/04/16
12/04
16:01
12/04/16
16:01
Hot Stocks
Aduro Biotech reports presentation of BION-1301 data »

Aduro Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$6.70

-0.5 (-6.94%)

15:59
12/04/16
12/04
15:59
12/04/16
15:59
Hot Stocks
Trillium Therapeutics reports presentation of TTI-621 data »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

BLUE

bluebird bio

$69.75

1.1 (1.60%)

15:47
12/04/16
12/04
15:47
12/04/16
15:47
Hot Stocks
bluebird bio reports new data from HGB-205 study of LentiGlobin »

bluebird bio announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLCM

Bellicum Pharmaceuticals

$18.72

1.74 (10.25%)

15:43
12/04/16
12/04
15:43
12/04/16
15:43
Hot Stocks
Bellicum Pharmaceuticals reports updated data from BPX-501 study »

Bellicum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

ALNY

Alnylam

$41.57

-0.01 (-0.02%)

15:39
12/04/16
12/04
15:39
12/04/16
15:39
Hot Stocks
Alnylam reports Phase 1 givosiran data, says plans Phase 3 study late 2017 »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$31.63

0.17 (0.54%)

, ONCE

Spark Therapeutics

$50.01

0.27 (0.54%)

15:32
12/04/16
12/04
15:32
12/04/16
15:32
Hot Stocks
Spark Therapeutics, Pfizer report updated preliminary data on SPK-9001 »

Spark Therapeutics (ONCE)…

PFE

Pfizer

$31.63

0.17 (0.54%)

ONCE

Spark Therapeutics

$50.01

0.27 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 04

    Dec

  • 06

    Dec

  • 06

    Dec

SGEN

Seattle Genetics

$66.70

-0.01 (-0.01%)

15:26
12/04/16
12/04
15:26
12/04/16
15:26
Conference/Events
Seattle Genetics to hold an investor reception »

Management reviews the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$27.20

-0.1 (-0.37%)

15:21
12/04/16
12/04
15:21
12/04/16
15:21
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

15:17
12/04/16
12/04
15:17
12/04/16
15:17
Hot Stocks
Juno Therapeutics reports Phase 1 data on JCAR014 »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.